These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29293020)

  • 21. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?
    Numbere N; Huber AR; Shi C; Cates JMM; Gonzalez RS
    Histopathology; 2019 Feb; 74(3):424-429. PubMed ID: 30326145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
    Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey.
    Karamchandani DM; Cox B; La Rosa S; Bellizzi AM; Shi C; Gonzalez RS
    Histopathology; 2023 Mar; 82(4):541-554. PubMed ID: 36507623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.
    Blank A; Wehweck L; Marinoni I; Boos LA; Bergmann F; Schmitt AM; Perren A
    Virchows Arch; 2015 Nov; 467(5):543-50. PubMed ID: 26384025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning.
    Govind D; Jen KY; Matsukuma K; Gao G; Olson KA; Gui D; Wilding GE; Border SP; Sarder P
    Sci Rep; 2020 Jul; 10(1):11064. PubMed ID: 32632119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms.
    Shaker N; Shen R; Limbach AL; Satturwar S; Kobalka P; Ahmadian S; Sun S; Chen W; Lujan G; Esnakula A; Parwani A; Li Z
    J Am Soc Cytopathol; 2024; 13(3):205-212. PubMed ID: 38433072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the Ki67 labeling index: a Japanese validation ring study.
    Niikura N; Sakatani T; Arima N; Ohi Y; Honma N; Kanomata N; Yoshida K; Kadoya T; Tamaki K; Kumaki N; Iwamoto T; Sugie T; Moriya T
    Breast Cancer; 2016 Jan; 23(1):92-100. PubMed ID: 24794952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.
    Warth A; Fink L; Fisseler-Eckhoff A; Jonigk D; Keller M; Ott G; Rieker RJ; Sinn P; Söder S; Soltermann A; Willenbrock K; Weichert W;
    Virchows Arch; 2013 May; 462(5):507-13. PubMed ID: 23559305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.
    Luchini C; Pantanowitz L; Adsay V; Asa SL; Antonini P; Girolami I; Veronese N; Nottegar A; Cingarlini S; Landoni L; Brosens LA; Verschuur AV; Mattiolo P; Pea A; Mafficini A; Milella M; Niazi MK; Gurcan MN; Eccher A; Cree IA; Scarpa A
    Mod Pathol; 2022 Jun; 35(6):712-720. PubMed ID: 35249100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
    He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
    Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
    Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.
    Tracht J; Zhang K; Peker D
    J Histochem Cytochem; 2017 Jul; 65(7):399-405. PubMed ID: 28651471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.
    Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML
    Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors.
    Philips P; Kooby DA; Maithel S; Merchant NB; Weber SM; Winslow ER; Ahmad S; Kim HJ; Scoggins CR; McMasters KM; Martin RCG
    Pancreas; 2018 Mar; 47(3):326-331. PubMed ID: 29351120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
    Lee HE; Mounajjed T; Erickson LA; Wu TT
    Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G; La Rosa S
    Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.